Aptose Biosciences Stock Price on August 9, 2024
| APTO Stock | USD 0.18 0.01 5.26% |
Below is the normalized historical share price chart for Aptose Biosciences extending back to March 16, 1992. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aptose Biosciences stands at 0.18, as last reported on the 26th of November, with the highest price reaching 0.19 and the lowest price hitting 0.17 during the day.
If you're considering investing in Aptose Stock, it is important to understand the factors that can impact its price. Aptose Biosciences secures Sharpe Ratio (or Efficiency) of -0.21, which signifies that the company had a -0.21% return per unit of risk over the last 3 months. Aptose Biosciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aptose Biosciences' Mean Deviation of 3.64, risk adjusted performance of (0.14), and Standard Deviation of 5.4 to double-check the risk estimate we provide.
At this time, Aptose Biosciences' Common Stock Shares Outstanding is very stable compared to the past year. As of the 26th of November 2024, Other Stockholder Equity is likely to grow to about 75.8 M, though Total Stockholder Equity is likely to grow to (2.8 M). . As of the 26th of November 2024, Price To Sales Ratio is likely to drop to 12.36. In addition to that, Price Earnings Ratio is likely to drop to -0.35. Aptose Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of October 2014 | 200 Day MA 0.8837 | 50 Day MA 0.3756 | Beta 1.364 |
Aptose |
Sharpe Ratio = -0.206
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | APTO |
Estimated Market Risk
| 5.43 actual daily | 48 52% of assets are more volatile |
Expected Return
| -1.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aptose Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aptose Biosciences by adding Aptose Biosciences to a well-diversified portfolio.
Price Book 67.8375 | Book Value (0.36) | Enterprise Value -3.9 M | Enterprise Value Ebitda 0.0496 | Shares Float 11.6 M |
Related Headline
Gain Therapeutics Headline on 9th of August 2024
Acquisition by Khalid Islam of 50000 shares of Gain Therapeu... by MacroaxisInsider
Filed transaction by Gain Therapeutics Director, Officer: Executive Chairman. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Aptose Biosciences Valuation on August 9, 2024
It is possible to determine the worth of Aptose Biosciences on a given historical date. On August 9, 2024 Aptose was worth 0.54 at the beginning of the trading date compared to the closed value of 0.51. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aptose Biosciences stock. Still, in general, we apply an absolute valuation method to find Aptose Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aptose Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aptose Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 0.50 | 0.57 | 0.46 | 0.56 | 102,930 | |
08/09/2024 | 0.54 | 0.54 | 0.50 | 0.51 | 39,933 |
| 0.52 | 0.52 | 0.47 | 0.47 | 31,121 |
| Backtest Aptose Biosciences | | | Aptose Biosciences History | | | Aptose Biosciences Valuation | Previous | Next |
Aptose Biosciences Trading Date Momentum on August 9, 2024
| On August 12 2024 Aptose Biosciences was traded for 0.47 at the closing time. The top price for the day was 0.52 and the lowest listed price was 0.47 . The trading volume for the day was 31.1 K. The trading history from August 12, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 7.84% . The overall trading delta against the current closing price is 1.96% . |
Aptose Biosciences Fundamentals Correlations and Trends
By evaluating Aptose Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aptose Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aptose financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Aptose Biosciences Stock history
Aptose Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aptose is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aptose Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aptose Biosciences stock prices may prove useful in developing a viable investing in Aptose Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 6.8 M | 7.1 M | |
| Net Loss | -37.6 M | -35.8 M |
Aptose Biosciences Stock Technical Analysis
Aptose Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Aptose Biosciences Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Aptose Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Aptose Biosciences November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Aptose Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aptose Biosciences shares will generate the highest return on investment. By undertsting and applying Aptose Biosciences stock market strength indicators, traders can identify Aptose Biosciences entry and exit signals to maximize returns
Aptose Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aptose Biosciences' price direction in advance. Along with the technical and fundamental analysis of Aptose Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aptose to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.95) | |||
| Total Risk Alpha | (1.89) | |||
| Treynor Ratio | 1.2 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptose Biosciences. If investors know Aptose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptose Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.92) | Return On Assets (1.36) | Return On Equity (6.94) |
The market value of Aptose Biosciences is measured differently than its book value, which is the value of Aptose that is recorded on the company's balance sheet. Investors also form their own opinion of Aptose Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aptose Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptose Biosciences' market value can be influenced by many factors that don't directly affect Aptose Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.